<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <link rel="icon" href="Conferimgs/visioneurLogoHigh.png" type="image/x-icon">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Cancer Innovation - VISION Europe 2030</title>

    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Sofia">
    <link href="https://fonts.googleapis.com/css?family=Montserrat:700" rel="stylesheet">

    <link href="https://fonts.googleapis.com/css2?family=Poppins:wght@400;600;700&display=swap" rel="stylesheet">

    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <link rel="stylesheet" href="css/styles.css">
    <link rel="stylesheet" href="css/themeStyles.css">
</head>

<body>
    <!-- Header -->
    <header>
        <div class="logo">
            <div style="display: flex; flex-direction: row; align-items: center;"><img src="Conferimgs/visioneurLogoHigh.png" style="width: 50px; height: auto;"><a href="index.html" style="color: #333333;">   
                VISION Europe 2030</a>
            </div>
            <button onclick="MobileHamBurgerMenu()"><i class="fa fa-bars hamico"></i></button>
        </div>

        <nav id="nav-menu">
            <ul>
                <li><a href="index.html"><i class="fas fa-home"></i> Home</a></li>
                <li><a href="about.html"><i class="fas fa-info-circle"></i> About</a></li>
                <li><a href="agenda.html"><i class="fas fa-calendar-alt"></i> Programme & Sessions</a></li>
                <li><a href="speakers.html"><i class="fas fa-microphone"></i> Speakers & Moderators</a></li>
            </ul>
        </nav>
    </header>


    <div class="hero-menu">
        <ul class="hero-menu-list">
            <li><a href="theme1.html">Cancer Innovation<br><p class="topic-header">Reforming Policy to Deliver Precision Tools to Patients</p></a></li>
            <li><a href="theme2.html">Innovative Trials<br>
                <p class="topic-header">How Data, Decentralisation, and Design Can Democratise Research</p></a></li>
            <li><a href="theme3.html">Precision Oncology<br><p class="topic-header">Rethinking Access, Approvals, and Genomic Strategy</p></a></li>
            <li><a href="theme4.html">Public-Private Partnerships<br><p class="topic-header">Aligning Public Value and Private Investment in Health Innovation</p></a></li>
            <li><a href="theme5.html">Precision Health<br><p class="topic-header">Neurology, Cardiology, and Chronic Disease in the AI Era</p></a></li>
            <li><a href="theme6.html">Genomic Equity<br><p class="topic-header">Toward a Technology-Driven Cancer Control Framework</p></a></li>
        </ul>
    </div>
    <section class="conference-theme">
        <div>
            <h1>Cancer Innovation</h1>
            <img src="Conferimgs/theme2-1.JPG" alt="confer-image" class="theme-image" />
        </div>
        <div>

            <h4>Reforming Policy to Deliver Precision Tools to Patients</h4>
            <p class="italic-quote">“Validated. Scalable. Still out of reach.”</p>
            <p class="theme-para-main">
                Breakthroughs in oncology diagnostics, such as circulating tumour DNA (ctDNA), liquid biopsy, and AI-enhanced pathology, have matured to the point of clinical validation. Their potential to transform patient outcomes through earlier detection, recurrence monitoring, and stratified treatment decisions is beyond dispute. However, widespread implementation remains elusive. Less than 20% of eligible patients across high-income European countries benefit from these innovations, reflecting a structural failure in the policy and delivery ecosystem.
            </p>
            <p class="theme-para-main">
                This session will critically examine the systemic bottlenecks that delay the adoption of precision diagnostics. These include fragmented and inconsistent reimbursement frameworks across Member States, misalignment between regulatory pathways and the speed of innovation, and a lack of coordinated EU-level procurement mechanisms for diagnostic technologies. While pilot programmes in countries like Germany and the Netherlands have demonstrated the feasibility of integrating ctDNA testing and AI-assisted pathology into oncology care, these remain the exception rather than the rule.
            </p>
            <p class="theme-para-main">
                Drawing on the policy priorities of EU4Health, the European Health Data Space (EHDS), and the ongoing implementation of the HTA Regulation, the discussion will present concrete policy pathways to scale diagnostic innovation. Key topics will include joint EU–national regulatory frameworks, value-based pricing models for diagnostics, embedding AI into standard pathology workflows, and the role of cross-border molecular diagnostics in ensuring equitable access.
            </p>
            <p class="theme-para-main">
                EAPM has long advocated for the systemic integration of innovation-readiness into national cancer control plans, including readiness assessments, interoperable data infrastructures, and public-private models for diagnostic procurement. This session aligns with the broader aim of moving beyond fragmented pilot projects to a harmonised European approach that supports timely, equitable, and scalable adoption of advanced diagnostics.
            </p>
            <b class="bold-question">Conclusion: </b>
            <p class="theme-para-main">Closing the implementation gap in cancer diagnostics is no longer a matter of evidence generation but of governance, alignment, and systemic reform. Europe's cancer systems must be reconfigured to deliver precision tools not only with scientific excellence, but with equity, efficiency, and urgency.</p>
        </div>

    </section>

    <!-- Footer -->
    <footer>
        <div class="logo-area">
            <img src="Conferimgs/eapmlogo_white.png" alt="VISION Europe 2030 Logo white">
            <p>In a world that’s increasingly interconnected and diverse, EAPM is dedicated to spearheading a
                new era in healthcare — one where precision and personalization redefine the standards of
                prevention and treatment strategies. Join us in exploring the forefront of medical innovation,
                where our commitment to individualized care is not just a goal but a revolution.</p>
        </div>
        <hr>
        <div class="social-links-area">
            <h1>Contact Us</h1>
            <p>If you have any questions or need more information about VISION Europe 2030, please reach out to us:</p>

            <a class="email-btn" href="mailto:denishorgan@euapm.eu"><i class="fa-solid fa-paper-plane"></i> E-mail Us</a>

            <div class="office-addr">
                <h2>Office</h2>
                <p><b>European Alliance For Personalized Medicine</b><br>
                    Avenue de l’Armee Legerlaan 10 1041 Brussels</p>
            </div>

            <!-- <h1>Media Centres & Social Hub</h1>
            <div class="media-centres">
                <a>Gallery</a>
                <a>News</a>
                <a>Press Releases</a>
                <a>Interview highlights</a>
            </div> -->

            <section class="box-links-follow">
                <section>
                    <h1>Go Back On</h1>
                    <div class="go-back-links">
                        <a href="index.html">Home</a>
                        <a href="about.html">About</a>
                        <a href="#">Register</a>
                    </div>
                </section>
                <section>
                    <h1>Follow Us</h1>
                    <div class="social-links">
                        <a href="https://x.com/euapmbrussels?ref_src=twsrc%5Etfw" target="_blank"><i
                                class="fab fa-twitter"></i></a>
                        <a href="https://www.linkedin.com/company/european-alliance-for-personalised-medicine-eapm/" target="_blank"><i class="fab fa-linkedin-in"></i></a>
                    </div>
                    <p>&copy; 2024 EAPM. All rights reserved.</p>
                </section>

        </div>

        </div>

    </footer>
    <script>
        function MobileHamBurgerMenu() {
            var x = document.getElementById("nav-menu");
            if (x.style.display === "block") {
                x.style.display = "none";
            } else {
                x.style.display = "block";
            }
        }

    </script>

</body>

</html>